Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study
Crossref DOI link: https://doi.org/10.1007/s11523-014-0355-4
Published Online: 2015-01-06
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kosty, Michael P.
Wozniak, Antoinette J.
Jahanzeb, Mohammad
Leon, Larry
Fish, Susan
Hazard, Sebastien J.
Lynch, Thomas J. Jr.
Text and Data Mining valid from 2015-01-06
Article History
Received: 22 August 2014
Accepted: 18 December 2014
First Online: 6 January 2015